Clinical trial
Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable…
NCT00450203 · Professor David Cunningham, Other · Unknown status
Key facts
| NCT number | NCT00450203 |
|---|---|
| Title | Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer |
| Official title | A Randomised Phase II/III Trial of Peri-Operative Chemotherapy With or Without Bevacizumab in Operable Oesophagogastric Adenocarcinoma and A Feasibility Study Evaluating Lapatinib in HER-2 Positive Oesophagogastric Adenocarcinomas and (in Selected Centres) MRI and PET/CT Sub-studies |
| Acronym | ST03 |
| Lead sponsor | Professor David Cunningham, Other |
| Collaborators | Cancer Research UK Roche Pharma AG Industry GlaxoSmithKline |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Oesophagogastric Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | bevacizumab, capecitabine, cisplatin, Epirubicin, adjuvant therapy, conventional surgery, neoadjuvant therapy, Lapatinib |
| Enrollment | 1,103 |
| Start date | Oct 1, 2007 |
| Primary completion | Dec 1, 2017 |
| Completion | Dec 1, 2017 |
| First posted | Mar 22, 2007 |
| Last update posted | Dec 1, 2016 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: